Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
12
SHWGY Quote, Financials, Valuation and Earnings
Last price:
$2.54
Seasonality move
:
-2.37%
Day range:
$2.54 - $2.54
52-week range:
$2.06 - $3.51
Dividend yield:
4.84%
P/E ratio:
10.64x
P/S ratio:
1.60x
P/B ratio:
4.53x
Volume:
--
Avg. volume:
68
1-year change:
5.18%
Market cap:
$2.8B
Revenue:
$1.8B
EPS (TTM):
$0.24
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SHWGY
Shandong Weigao Group Medical Polymer Co. Ltd.
|
-- | -- | -- | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -$0.34 | -- | -- | $9.22 |
|
CASI
CASI Pharmaceuticals, Inc.
|
-- | -- | -100% | -- | $4.00 |
|
CPHI
China Pharma Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$138M | -$0.28 | 16.92% | -46.43% | $49.49 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SHWGY
Shandong Weigao Group Medical Polymer Co. Ltd.
|
$2.54 | -- | $2.8B | 10.64x | $0.05 | 4.84% | 1.60x |
|
ADAG
Adagene, Inc.
|
$1.83 | $9.22 | $86.2M | -- | $0.00 | 0% | 823.60x |
|
CASI
CASI Pharmaceuticals, Inc.
|
$0.83 | $4.00 | $17.1M | -- | $0.00 | 0% | 0.48x |
|
CPHI
China Pharma Holdings, Inc.
|
$1.44 | -- | $4.7M | -- | $0.00 | 0% | 1.16x |
|
SVA
Sinovac Biotech Ltd.
|
$6.47 | -- | $464.9M | -- | $55.00 | 0% | 1.50x |
|
ZLAB
Zai Lab Ltd.
|
$17.18 | $49.49 | $1.9B | -- | $0.00 | 0% | 4.17x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SHWGY
Shandong Weigao Group Medical Polymer Co. Ltd.
|
14.42% | 0.076 | -- | 2.59x |
|
ADAG
Adagene, Inc.
|
26.49% | 2.508 | -- | 2.23x |
|
CASI
CASI Pharmaceuticals, Inc.
|
-274.41% | 0.019 | 55.28% | 0.19x |
|
CPHI
China Pharma Holdings, Inc.
|
29.58% | -1.772 | 56.09% | 0.09x |
|
SVA
Sinovac Biotech Ltd.
|
3.46% | 7.067 | 12.91% | 11.22x |
|
ZLAB
Zai Lab Ltd.
|
22.4% | 0.005 | 5.85% | 2.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SHWGY
Shandong Weigao Group Medical Polymer Co. Ltd.
|
-- | -- | 7.23% | 8.41% | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -- | -42.07% | -56.44% | -- | -- |
|
CASI
CASI Pharmaceuticals, Inc.
|
$706K | -$10.2M | -405.32% | -70405.41% | -333.14% | -- |
|
CPHI
China Pharma Holdings, Inc.
|
-$257.6K | -$628.1K | -29.08% | -43.41% | -83.07% | -$277.6K |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -1.02% | -1.05% | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$69.3M | -$48.9M | -21.74% | -26.7% | -42.05% | -$44.5M |
Shandong Weigao Group Medical Polymer Co. Ltd. vs. Competitors
-
Which has Higher Returns SHWGY or ADAG?
Adagene, Inc. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat Adagene, Inc.'s return on equity of -56.44%.
Company Gross Margin Earnings Per Share Invested Capital SHWGYShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B ADAGAdagene, Inc.-- -- $68.7M -
What do Analysts Say About SHWGY or ADAG?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Adagene, Inc. has an analysts' consensus of $9.22 which suggests that it could grow by 404.06%. Given that Adagene, Inc. has higher upside potential than Shandong Weigao Group Medical Polymer Co. Ltd., analysts believe Adagene, Inc. is more attractive than Shandong Weigao Group Medical Polymer Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGYShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 ADAGAdagene, Inc.6 2 0 -
Is SHWGY or ADAG More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of 0.059, which suggesting that the stock is 94.08% less volatile than S&P 500. In comparison Adagene, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SHWGY or ADAG?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.05 per share corresponding to a yield of 4.84%. Adagene, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 33.3% of its earnings as a dividend. Adagene, Inc. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGY or ADAG?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than Adagene, Inc. quarterly revenues of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than Adagene, Inc.'s net income of --. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 10.64x while Adagene, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.60x versus 823.60x for Adagene, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGYShandong Weigao Group Medical Polymer Co. Ltd.1.60x 10.64x -- -- ADAGAdagene, Inc.823.60x -- -- --
-
Which has Higher Returns SHWGY or CASI?
CASI Pharmaceuticals, Inc. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of -353.92%. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat CASI Pharmaceuticals, Inc.'s return on equity of -70405.41%.
Company Gross Margin Earnings Per Share Invested Capital SHWGYShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B CASICASI Pharmaceuticals, Inc.22.96% -$0.68 -$6.9M -
What do Analysts Say About SHWGY or CASI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand CASI Pharmaceuticals, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 381.06%. Given that CASI Pharmaceuticals, Inc. has higher upside potential than Shandong Weigao Group Medical Polymer Co. Ltd., analysts believe CASI Pharmaceuticals, Inc. is more attractive than Shandong Weigao Group Medical Polymer Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGYShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 CASICASI Pharmaceuticals, Inc.1 0 0 -
Is SHWGY or CASI More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of 0.059, which suggesting that the stock is 94.08% less volatile than S&P 500. In comparison CASI Pharmaceuticals, Inc. has a beta of 0.853, suggesting its less volatile than the S&P 500 by 14.657%.
-
Which is a Better Dividend Stock SHWGY or CASI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.05 per share corresponding to a yield of 4.84%. CASI Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 33.3% of its earnings as a dividend. CASI Pharmaceuticals, Inc. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGY or CASI?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than CASI Pharmaceuticals, Inc. quarterly revenues of $3.1M. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than CASI Pharmaceuticals, Inc.'s net income of -$10.9M. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 10.64x while CASI Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.60x versus 0.48x for CASI Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGYShandong Weigao Group Medical Polymer Co. Ltd.1.60x 10.64x -- -- CASICASI Pharmaceuticals, Inc.0.48x -- $3.1M -$10.9M
-
Which has Higher Returns SHWGY or CPHI?
China Pharma Holdings, Inc. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of -86.16%. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat China Pharma Holdings, Inc.'s return on equity of -43.41%.
Company Gross Margin Earnings Per Share Invested Capital SHWGYShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M -
What do Analysts Say About SHWGY or CPHI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand China Pharma Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Shandong Weigao Group Medical Polymer Co. Ltd. has higher upside potential than China Pharma Holdings, Inc., analysts believe Shandong Weigao Group Medical Polymer Co. Ltd. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHWGYShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 CPHIChina Pharma Holdings, Inc.0 0 0 -
Is SHWGY or CPHI More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of 0.059, which suggesting that the stock is 94.08% less volatile than S&P 500. In comparison China Pharma Holdings, Inc. has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.826%.
-
Which is a Better Dividend Stock SHWGY or CPHI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.05 per share corresponding to a yield of 4.84%. China Pharma Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 33.3% of its earnings as a dividend. China Pharma Holdings, Inc. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGY or CPHI?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than China Pharma Holdings, Inc. quarterly revenues of $756.2K. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than China Pharma Holdings, Inc.'s net income of -$651.5K. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 10.64x while China Pharma Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.60x versus 1.16x for China Pharma Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGYShandong Weigao Group Medical Polymer Co. Ltd.1.60x 10.64x -- -- CPHIChina Pharma Holdings, Inc.1.16x -- $756.2K -$651.5K
-
Which has Higher Returns SHWGY or SVA?
Sinovac Biotech Ltd. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat Sinovac Biotech Ltd.'s return on equity of -1.05%.
Company Gross Margin Earnings Per Share Invested Capital SHWGYShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B SVASinovac Biotech Ltd.-- -- $11.8B -
What do Analysts Say About SHWGY or SVA?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sinovac Biotech Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Shandong Weigao Group Medical Polymer Co. Ltd. has higher upside potential than Sinovac Biotech Ltd., analysts believe Shandong Weigao Group Medical Polymer Co. Ltd. is more attractive than Sinovac Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGYShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 SVASinovac Biotech Ltd.0 0 0 -
Is SHWGY or SVA More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of 0.059, which suggesting that the stock is 94.08% less volatile than S&P 500. In comparison Sinovac Biotech Ltd. has a beta of 0.723, suggesting its less volatile than the S&P 500 by 27.741%.
-
Which is a Better Dividend Stock SHWGY or SVA?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.05 per share corresponding to a yield of 4.84%. Sinovac Biotech Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $55.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 33.3% of its earnings as a dividend. Sinovac Biotech Ltd. pays out -328.35% of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGY or SVA?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than Sinovac Biotech Ltd. quarterly revenues of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than Sinovac Biotech Ltd.'s net income of --. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 10.64x while Sinovac Biotech Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.60x versus 1.50x for Sinovac Biotech Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGYShandong Weigao Group Medical Polymer Co. Ltd.1.60x 10.64x -- -- SVASinovac Biotech Ltd.1.50x -- -- --
-
Which has Higher Returns SHWGY or ZLAB?
Zai Lab Ltd. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of -30.98%. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat Zai Lab Ltd.'s return on equity of -26.7%.
Company Gross Margin Earnings Per Share Invested Capital SHWGYShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B ZLABZai Lab Ltd.59.62% -$0.33 $979.3M -
What do Analysts Say About SHWGY or ZLAB?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Zai Lab Ltd. has an analysts' consensus of $49.49 which suggests that it could grow by 188.06%. Given that Zai Lab Ltd. has higher upside potential than Shandong Weigao Group Medical Polymer Co. Ltd., analysts believe Zai Lab Ltd. is more attractive than Shandong Weigao Group Medical Polymer Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGYShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 ZLABZai Lab Ltd.8 1 0 -
Is SHWGY or ZLAB More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of 0.059, which suggesting that the stock is 94.08% less volatile than S&P 500. In comparison Zai Lab Ltd. has a beta of 0.872, suggesting its less volatile than the S&P 500 by 12.778%.
-
Which is a Better Dividend Stock SHWGY or ZLAB?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.05 per share corresponding to a yield of 4.84%. Zai Lab Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 33.3% of its earnings as a dividend. Zai Lab Ltd. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGY or ZLAB?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than Zai Lab Ltd. quarterly revenues of $116.2M. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than Zai Lab Ltd.'s net income of -$36M. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 10.64x while Zai Lab Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.60x versus 4.17x for Zai Lab Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGYShandong Weigao Group Medical Polymer Co. Ltd.1.60x 10.64x -- -- ZLABZai Lab Ltd.4.17x -- $116.2M -$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 24.85% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is down 19.66% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is down 16.08% over the past day.
